logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Summy, Mohanjit Kaur
    Born in August 1958
    Individual (3 offsprings)
    Officer
    2014-12-17 ~ now
    OF - Director → CIF 0
Ceased 1
  • Ms Mohanjit Kaur Summy
    Born in August 1958
    Individual (3 offsprings)
    Person with significant control
    2017-02-01 ~ 2019-07-01
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

SAFFRON PHARMA CONSULTING LTD

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Property, Plant & Equipment
16,924 GBP2023-12-31
1,384 GBP2022-12-31
Debtors
153,360 GBP2023-12-31
26,674 GBP2022-12-31
Cash at bank and in hand
437,116 GBP2023-12-31
457,938 GBP2022-12-31
Current Assets
590,476 GBP2023-12-31
484,612 GBP2022-12-31
Creditors
Current
66,585 GBP2023-12-31
67,208 GBP2022-12-31
Net Current Assets/Liabilities
523,891 GBP2023-12-31
417,404 GBP2022-12-31
Total Assets Less Current Liabilities
540,815 GBP2023-12-31
418,788 GBP2022-12-31
Equity
Called up share capital
4 GBP2023-12-31
4 GBP2022-12-31
Retained earnings (accumulated losses)
540,811 GBP2023-12-31
418,784 GBP2022-12-31
Equity
540,815 GBP2023-12-31
418,788 GBP2022-12-31
Average Number of Employees
22023-01-01 ~ 2023-12-31
22022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
24,362 GBP2023-12-31
5,434 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
7,438 GBP2023-12-31
4,050 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
3,388 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Plant and equipment
16,924 GBP2023-12-31
1,384 GBP2022-12-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
30,360 GBP2023-12-31
26,585 GBP2022-12-31
Other Debtors
Current, Amounts falling due within one year
123,000 GBP2023-12-31
89 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
153,360 GBP2023-12-31
26,674 GBP2022-12-31
Other Taxation & Social Security Payable
Current
63,795 GBP2023-12-31
57,412 GBP2022-12-31
Other Creditors
Current
2,790 GBP2023-12-31
9,796 GBP2022-12-31

  • SAFFRON PHARMA CONSULTING LTD
    Info
    Registered number 09357972
    C/o Hillier Hopkins Llp First Floor, Radius House, 51 Clarendon Road, Watford, Hertfordshire WD17 1HP
    PRIVATE LIMITED COMPANY incorporated on 2014-12-17 (11 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.